Department of EndocrinologyAix Marseille University, CNRS UM 7286, Assistance Publique Hopitaux de Marseille, Marseille, France
Department of SurgeryWashington University School of Medicine, St Louis, Missouri, USA.
Endocr Relat Cancer. 2018 Feb;25(2):T29-T39. doi: 10.1530/ERC-17-0209. Epub 2017 Jul 11.
MEN2B is a very rare autosomal dominant hereditary tumor syndrome associated with medullary thyroid carcinoma (MTC) in 100% cases, pheochromocytoma in 50% cases and multiple extra-endocrine features, many of which can be quite disabling. Only few data are available in the literature. The aim of this review is to try to give further insights into the natural history of the disease and to point out the missing evidence that would help clinicians optimize the management of such patients. MEN2B is mainly characterized by the early occurrence of MTC, which led the American Thyroid Association to recommend preventive thyroidectomy before the age of 1 year. However, as the majority of mutations are , improved knowledge of the nonendocrine signs would help to lower the age of diagnosis and improve long-term outcomes. Future large-scale studies will be aimed at characterizing more in detail the main characteristics and outcomes of MEN2B.
MEN2B 是一种非常罕见的常染色体显性遗传性肿瘤综合征,与 100%病例中的甲状腺髓样癌(MTC)、50%病例中的嗜铬细胞瘤以及多种内分泌外特征相关,其中许多特征可能会严重致残。文献中仅有少量数据。本综述的目的是试图进一步深入了解疾病的自然病程,并指出有助于临床医生优化此类患者管理的缺失证据。MEN2B 的主要特征是 MTC 的早期发生,这促使美国甲状腺协会建议在 1 岁之前进行预防性甲状腺切除术。然而,由于大多数突变是 ,因此更好地了解非内分泌征象将有助于降低诊断年龄并改善长期结局。未来的大规模研究将旨在更详细地描述 MEN2B 的主要特征和结局。